Committee on Chinese Medicine and Pharmacy Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2009
NCT01580358
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

qi-tonifying (1 trial)

Drugs in Other Trials (2)

shen-mai san (1 trial)

starch (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3